Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3586 publications
Solvotrin Therapeutics Ltd - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of Solvotrin Therapeutics Ltd including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Solvotrin Therapeutics Ltd’s pipeline products Reasons ...

Dec, 2014 18 pages
Protagonist Therapeutics Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Protagonist Therapeutics Inc.’s pipeline products Reasons to ...

Dec, 2014 28 pages
Melinta Therapeutics, Inc - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of Melinta Therapeutics, Inc including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Melinta Therapeutics, Inc’s pipeline products Reasons ...

Dec, 2014 49 pages
Amarna Therapeutics B.V. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Amarna Therapeutics B.V.’s pipeline products ...

Dec, 2014 23 pages
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth US$ 4,995.00

... business intelligence provider, has released its latest research, “Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to ... size, trial duration and program failure rate for each molecule type Multi-scenario market forecast data to 2020, taking into account ...

Nov, 2014 107 pages
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 US$ 3,995.00

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 SUMMARY Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body’s immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, ...

Dec, 2014 48 pages
EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023 US$ 3,995.00

EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023 SUMMARY Acromegaly and gigantism are rare disorders of the pituitary gland characterized ... . The 6MM had an estimated 22,408 diagnosed prevalent cases of acromegaly and gigantism receiving any surgical treatment in 2013, and the number ...

Dec, 2014 58 pages
US Proton Therapy Market Opportunity Analysis US$ 1,500.00

... . In US, there are 14 proton therapy centers catering to a potential patient base of more than 350,000 cancer patients with respect to treatment with ... to see American centers upgrading to intensity modulated proton beam therapy that will make it more accurate. “US Proton Therapy Market Opportunity Analysis ...

Dec, 2014 87 pages
Prexton Therapeutics SA - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Prexton Therapeutics SA’s pipeline products ...

Nov, 2014 18 pages
Mission Therapeutics Ltd - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of Mission Therapeutics Ltd including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Mission Therapeutics Ltd’s pipeline products Reasons to ...

Nov, 2014 17 pages
Minoryx Therapeutics s.l. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Minoryx Therapeutics s.l.’s pipeline products ...

Nov, 2014 19 pages
Kareus Therapeutics, SA - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Kareus Therapeutics, SA’s pipeline products ...

Nov, 2014 23 pages
Io Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Io Therapeutics, Inc.’s human ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Io Therapeutics, Inc.’s pipeline products ...

Nov, 2014 26 pages
IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of IMPACT Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the IMPACT Therapeutics, Inc.’s pipeline products Reasons ...

Nov, 2014 35 pages
Escape Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of Escape Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Escape Therapeutics, Inc.’s pipeline products Reasons ...

Nov, 2014 27 pages
Ecrins Therapeutics SAS - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... disease. Scope The report provides brief overview of Ecrins Therapeutics SAS including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Ecrins Therapeutics SAS’s pipeline products Reasons to ...

Nov, 2014 22 pages
Domain Therapeutics SA - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Domain Therapeutics SA’s pipeline products ...

Nov, 2014 32 pages
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

... Aureus Infection (VRSA) - Pipeline Review, H2 2014’, provides an overview of the Vancomycin Resistant Staphylococcus Aureus Infection (VRSA)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vancomycin Resistant Staphylococcus Aureus Infection (VRSA), ...

Nov, 2014 49 pages
Intracerebral Hemorrhage - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

Intracerebral Hemorrhage - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Intracerebral Hemorrhage - Pipeline Review, H2 2014’, provides an overview of the Intracerebral Hemorrhage’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ...

Nov, 2014 38 pages
Epstein-Barr Viral Infections - Pipeline Review, H2 2014 US$ 2,000.00 US$ 1,800.00

... , H2 2014’, provides an overview of the Epstein-Barr Viral Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Nov, 2014 54 pages
Global Schizophrenia Therapeutics Market 2014-2018 US$ 3,000.00

... generation Antipsychotics and Second-generation Antipsychotics. TechNavio's report, the Global Schizophrenia Therapeutics Market 2014-2018, has been prepared based on an in-depth ... report Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are ...

Nov, 2014 102 pages
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight US$ 2,400.00

... market approval by the FDA in 2013 for the treatment of mantel cell lymphoma. In 2014, this drug also got the FDA’s approval for chronic ... size of Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview ...

Nov, 2014 573 pages
ORCA Therapeutics B.V. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of ORCA Therapeutics B.V.’s human ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the ORCA Therapeutics B.V.’s pipeline products ...

Nov, 2014 22 pages
ADC Therapeutics Sarl - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... indicated disease. Scope The report provides brief overview of ADC Therapeutics Sarl including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the ADC Therapeutics Sarl’s pipeline products Reasons ...

Nov, 2014 25 pages
Global Cushing's Syndrome Therapeutics Market 2015-2019 US$ 2,500.00

... and a corresponding detailed analysis of the top vendors in the Global Cushing's Syndrome Therapeutics market. In addition, the report discusses the major drivers ... Adverse Effects of Drugs For a full, detailed list, view our report Market Trend Increase in Awareness For a full, detailed list, view our ...

Nov, 2014 69 pages
Global Antisense and RNAi Therapeutics Market 2015-2019 US$ 2,500.00

... that are used in the treatment of serious chronic and rare diseases. RNAi is a RNA-based gene silencing process in which RNA molecules inhibit gene ... technology: miRNA and siRNA. TechNavio's analysts forecast the Global Antisense and RNAi Therapeutics market to grow at a CAGR of 26.79 percent over the period ...

Nov, 2014 70 pages
Peptide Therapeutics Pipeline Database: 1-Year Subscription US$ 1,000.00

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each ...

Nov, 2014
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options US$ 4,995.00

... intelligence provider, has released its latest research report, “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising ... pipeline, and key licensing and co-development deals in the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and ...

Oct, 2014 109 pages
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth US$ 4,995.00

... intelligence provider, has released its latest research report, 'Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive ... new drugs and changes in disease epidemiology across the key developed markets, the US, Canada, the UK, France, Germany, Italy, Spain and Japan. ...

Sep, 2014 189 pages
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries US$ 4,995.00

... business intelligence provider, has released its latest research, 'Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest ... analysis and key licensing and co-development deals MDD in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan ...

Oct, 2014 70 pages
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts US$ 4,995.00

... Research, has released its latest pharma report, 'Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small ... agents, whether in combination or as monotherapies. There are clear gaps in the market for therapies to meet several unmet needs by increasing the initial ...

Sep, 2014 163 pages
Spain Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Spain Compression Therapy Market Outlook to 2020', provides key market data on the Spain Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 69 pages
Russia Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Russia Compression Therapy Market Outlook to 2020', provides key market data on the Russia Compression Therapy market. The report ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 69 pages
North America Compression Therapy Market Outlook to 2020 US$ 3,000.00

... Market Outlook to 2020', provides key market data on the North America Compression Therapy market. The report provides value, in millions of US dollars, volume ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 182 pages
Mexico Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Mexico Compression Therapy Market Outlook to 2020', provides key market data on the Mexico Compression Therapy market. The report ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 68 pages
Japan Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Japan Compression Therapy Market Outlook to 2020', provides key market data on the Japan Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 65 pages
Italy Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Italy Compression Therapy Market Outlook to 2020', provides key market data on the Italy Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 70 pages
Germany Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Germany Compression Therapy Market Outlook to 2020', provides key market data on the Germany Compression Therapy market. The report ... Innothera. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. ...

Oct, 2014 68 pages
EU5 Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 3,000.00

... (NPWT) Market Outlook to 2020 Summary GlobalData’s new report, 'EU5 Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020', provides key market data ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 127 pages
Canada Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Canada Compression Therapy Market Outlook to 2020', provides key market data on the Canada Compression Therapy market. The report ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 69 pages
BRIC Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 3,000.00

... (NPWT) Market Outlook to 2020 Summary GlobalData’s new report, 'BRIC Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020', provides key market data ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 103 pages
BRIC Compression Therapy Market Outlook to 2020 US$ 3,000.00

... GlobalData’s new report, 'BRIC Compression Therapy Market Outlook to 2020', provides key market data on the BRIC Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 224 pages
Brazil Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Brazil Compression Therapy Market Outlook to 2020', provides key market data on the Brazil Compression Therapy market. The report ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 67 pages
Australia Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'Australia Compression Therapy Market Outlook to 2020', provides key market data on the Australia Compression Therapy market. The report ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 66 pages
Asia-Pacific Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 3,000.00

... (NPWT) Market Outlook to 2020 Summary GlobalData’s new report, 'Asia-Pacific Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020', provides key ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 124 pages
Global Overactive Bladder Therapeutics Market 2014-2018 US$ 2,500.00

... 's disease and multiple sclerosis. TechNavio's analysts forecast the Global Overactive Bladder Therapeutics market to grow at a CAGR of 1.14 percent over the period 2013-2018. ... our report Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are ...

Nov, 2014 91 pages
Immunomic Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00 US$ 1,350.00

... of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Immunomic Therapeutics, Inc.’s pipeline products Reasons to ...

Oct, 2014 38 pages
South Korea Compression Therapy Market Outlook to 2020 US$ 2,500.00

... Market Outlook to 2020', provides key market data on the South Korea Compression Therapy market. The report provides value, in millions of US dollars, volume ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 67 pages
India Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'India Compression Therapy Market Outlook to 2020', provides key market data on the India Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 68 pages
China Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'China Compression Therapy Market Outlook to 2020', provides key market data on the China Compression Therapy market. The report ... market wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 67 pages
1 2 3 4 5 >
Skip to top